{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:01:39Z","timestamp":1740106899258,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00277-021-04668-9","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T07:12:42Z","timestamp":1633072362000},"page":"21-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction"],"prefix":"10.1007","volume":"101","author":[{"given":"Mitchell","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Movahed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrtash","family":"Hashemzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9292-9025","authenticated-orcid":false,"given":"Mehrnoosh","family":"Hashemzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"issue":"6, Supplement 1","key":"4668_CR1","doi-asserted-by":"publisher","first-page":"5B","DOI":"10.1016\/0002-9149(95)80003-B","volume":"75","author":"E Falk","year":"1995","unstructured":"Falk E, Fern\u00e1ndez-Ortiz A (1995) Role of thrombosis in atherosclerosis and its complications. Am J Cardiol 75(6, Supplement 1):5B-11B. https:\/\/doi.org\/10.1016\/0002-9149(95)80003-B","journal-title":"Am J Cardiol"},{"issue":"1","key":"4668_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1172\/JCI114138","volume":"84","author":"JF Eidt","year":"1989","unstructured":"Eidt JF, Allison P, Noble S et al (1989) Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury. J Clin Invest 84(1):18\u201327. https:\/\/doi.org\/10.1172\/JCI114138","journal-title":"J Clin Invest"},{"issue":"5","key":"4668_CR3","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1161\/01.CIR.90.5.2432","volume":"90","author":"BJ Meyer","year":"1994","unstructured":"Meyer BJ, Badimon JJ, Mailhac A et al (1994) Experimental myocardial ischemia\/infarction: inhibition of growth of thrombus on fresh mural thrombus: targeting optimal therapy. Circulation 90(5):2432\u20132438","journal-title":"Circulation"},{"issue":"7","key":"4668_CR4","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/0735-1097(90)90327-L","volume":"16","author":"T Yasuda","year":"1990","unstructured":"Yasuda T, Gold HK, Leinbach RC et al (1990) Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb\/IIIa antibody. J Am Coll Cardiol 16(7):1728\u20131735. https:\/\/doi.org\/10.1016\/0735-1097(90)90327-L","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"4668_CR5","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1172\/JCI113446","volume":"81","author":"T Yasuda","year":"1988","unstructured":"Yasuda T, Gold HK, Fallon JT et al (1988) Monoclonal antibody against the platelet glycoprotein (GP) IIb\/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. J Clin Invest 81(4):1284\u20131291. https:\/\/doi.org\/10.1172\/JCI113446","journal-title":"J Clin Invest"},{"issue":"4","key":"4668_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/0022-2828(89)90650-0","volume":"21","author":"JK Mickelson","year":"1989","unstructured":"Mickelson JK, Simpson PJ, Lucchesi BR (1989) Antiplatelet monoclonal F(ab\u2032)2 antibody directed against the platelet GPIIb IIIa receptor complex prevents coronary artery thrombosis in the canine heart. J Mol Cell Cardiol 21(4):393\u2013405. https:\/\/doi.org\/10.1016\/0022-2828(89)90650-0","journal-title":"J Mol Cell Cardiol"},{"issue":"24","key":"4668_CR7","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1056\/NEJMra071014","volume":"357","author":"G Dav\u00ec","year":"2007","unstructured":"Dav\u00ec G, Patrono C (2007) Platelet activation and atherothrombosis. N Engl J Med 357(24):2482\u20132494. https:\/\/doi.org\/10.1056\/NEJMra071014","journal-title":"N Engl J Med"},{"issue":"1","key":"4668_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1172\/JCI113311","volume":"81","author":"ME Mendelsohn","year":"1988","unstructured":"Mendelsohn ME, Loscalzo J (1988) Role of platelets in cholesteryl ester formation by U-937 cells. J Clin Invest 81(1):62\u201368. https:\/\/doi.org\/10.1172\/JCI113311","journal-title":"J Clin Invest"},{"issue":"3483","key":"4668_CR9","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1126\/science.134.3483.946","volume":"134","author":"AB Chandler","year":"1961","unstructured":"Chandler AB, Hand RA (1961) Phagocytized platelets: a source of lipids in human thrombi and atherosclerotic plaques. Science 134(3483):946\u2013947. https:\/\/doi.org\/10.1126\/science.134.3483.946","journal-title":"Science"},{"issue":"9","key":"4668_CR10","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1007\/s00277-020-04170-8","volume":"99","author":"F Haseefa","year":"2020","unstructured":"Haseefa F, Movahed MR, Hashemzadeh M, Hashemzadeh M (2020) Idiopathic thrombocytopenic purpura is strongly associated with higher prevalence of aortic valve disease. Ann Hematol 99(9):2081\u20132084. https:\/\/doi.org\/10.1007\/s00277-020-04170-8","journal-title":"Ann Hematol"},{"issue":"3","key":"4668_CR11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/jth.13940","volume":"16","author":"JS Chandan","year":"2018","unstructured":"Chandan JS, Thomas T, Lee S et al (2018) The association between idiopathic thrombocytopenic purpura and cardiovascular disease: a retrospective cohort study. J Thromb Haemost 16(3):474\u2013480. https:\/\/doi.org\/10.1111\/jth.13940","journal-title":"J Thromb Haemost"},{"issue":"2","key":"4668_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1510\/icvts.2011.271296","volume":"13","author":"A Russo","year":"2011","unstructured":"Russo A, Cannizzo M, Ghetti G et al (2011) Idiopathic thrombocytopenic purpura and coronary artery disease: comparison between coronary artery bypass grafting and percutaneous coronary intervention. Interact Cardiovasc Thorac Surg 13(2):153\u2013157. https:\/\/doi.org\/10.1510\/icvts.2011.271296","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"2","key":"4668_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12185-010-0636-3","volume":"92","author":"C Enger","year":"2010","unstructured":"Enger C, Bennett D, Forssen U, Fogarty PF, McAfee AT (2010) Comorbidities in patients with persistent or chronic immune thrombocytopenia. Int J Hematol 92(2):289\u2013295. https:\/\/doi.org\/10.1007\/s12185-010-0636-3","journal-title":"Int J Hematol"},{"key":"4668_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/963506","volume":"2009","author":"MA Feudjo-Tepie","year":"2009","unstructured":"Feudjo-Tepie MA, Le Roux G, Beach KJ, Bennett D, Robinson NJ (2009) Comorbidities of idiopathic thrombocytopenic purpura: a population-based study. Adv Hematol 2009:963506. https:\/\/doi.org\/10.1155\/2009\/963506","journal-title":"Adv Hematol"},{"issue":"4","key":"4668_CR15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1055\/s-0034-1544001","volume":"41","author":"A Cuker","year":"2015","unstructured":"Cuker A, Prak ETL, Cines DB (2015) Can immune thrombocytopenia be cured with medical therapy? Semin Thromb Hemost 41(4):395\u2013404. https:\/\/doi.org\/10.1055\/s-0034-1544001","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"4668_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2169\/internalmedicine.55.4544","volume":"55","author":"S Fujino","year":"2016","unstructured":"Fujino S, Niwa S, Fujioka K et al (2016) Primary percutaneous coronary intervention by a stentless technique for acute myocardial infarction with idiopathic thrombocytopenic purpura: a case report and review of the literature. Intern Med Tokyo Jpn 55(2):147\u2013152. https:\/\/doi.org\/10.2169\/internalmedicine.55.4544","journal-title":"Intern Med Tokyo Jpn"},{"issue":"4","key":"4668_CR17","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1182\/bloodadvances.2017010660","volume":"2","author":"TO Kim","year":"2018","unstructured":"Kim TO, Despotovic J, Lambert MP (2018) Eltrombopag for use in children with immune thrombocytopenia. Blood Adv 2(4):454\u2013461. https:\/\/doi.org\/10.1182\/bloodadvances.2017010660","journal-title":"Blood Adv"},{"issue":"11","key":"4668_CR18","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T et al (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386\u20132393. https:\/\/doi.org\/10.1182\/blood-2008-07-162503","journal-title":"Blood"},{"issue":"12","key":"4668_CR19","first-page":"775","volume":"15","author":"G Zaid","year":"2013","unstructured":"Zaid G, Dawod S, Rosenschein U (2013) Immune thrombocytopenic purpura and myocardial infarction: a dilemma of management. Isr Med Assoc J IMAJ 15(12):775\u2013776","journal-title":"Isr Med Assoc J IMAJ"},{"issue":"7","key":"4668_CR20","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1182\/blood-2004-12-4598","volume":"106","author":"DB Cines","year":"2005","unstructured":"Cines DB, Bussel JB (2005) How I treat idiopathic thrombocytopenic purpura (ITP). Blood 106(7):2244\u20132251. https:\/\/doi.org\/10.1182\/blood-2004-12-4598","journal-title":"Blood"},{"issue":"16","key":"4668_CR21","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1182\/blood-2010-08-302984","volume":"117","author":"C Neunert","year":"2011","unstructured":"Neunert C, Lim W, Crowther M et al (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117(16):4190\u20134207. https:\/\/doi.org\/10.1182\/blood-2010-08-302984","journal-title":"Blood"},{"issue":"2","key":"4668_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","volume":"115","author":"D Provan","year":"2010","unstructured":"Provan D, Stasi R, Newland AC et al (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115(2):168\u2013186. https:\/\/doi.org\/10.1182\/blood-2009-06-225565","journal-title":"Blood"},{"issue":"4","key":"4668_CR23","first-page":"334","volume":"119","author":"W Jy","year":"1992","unstructured":"Jy W, Horstman LL, Arce M, Ahn YS (1992) Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 119(4):334\u2013345","journal-title":"J Lab Clin Med"},{"issue":"4","key":"4668_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3109\/08880011003663390","volume":"27","author":"AAG Tantawy","year":"2010","unstructured":"Tantawy AAG, Matter RM, Hamed AA, Telbany MASEDE (2010) Pla\u2121et Microparticles in Immune Thrombocytopenic Purpura in Pediatrics. Pediatr Hematol Oncol 27(4):283\u2013296. https:\/\/doi.org\/10.3109\/08880011003663390","journal-title":"Pediatr Hematol Oncol"},{"issue":"4","key":"4668_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0049-3848(93)90138-e","volume":"72","author":"YJ Lee","year":"1993","unstructured":"Lee YJ, Jy W, Horstman LL et al (1993) Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res 72(4):295\u2013304. https:\/\/doi.org\/10.1016\/0049-3848(93)90138-e","journal-title":"Thromb Res"},{"issue":"9","key":"4668_CR26","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/00043426-200212000-00012","volume":"24","author":"L Olcay","year":"2002","unstructured":"Olcay L, Yenicesu I, Yetgin S (2002) Soluble P-selectin, interleukin 6, and thrombopoietin levels in children with acute and chronic idiopathic thrombocytopenic purpura and their relationship with mega-dose methylprednisolone therapy: a pilot study. J Pediatr Hematol Oncol 24(9):742\u2013745. https:\/\/doi.org\/10.1097\/00043426-200212000-00012","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"4668_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.critrevonc.2004.12.004","volume":"54","author":"B Zhou","year":"2005","unstructured":"Zhou B, Zhao H, Yang RC, Han ZC (2005) Multi-dysfunctional pathophysiology in ITP. Crit Rev Oncol Hematol 54(2):107\u2013116. https:\/\/doi.org\/10.1016\/j.critrevonc.2004.12.004","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"4668_CR28","first-page":"9","volume":"3","author":"S Takagi","year":"2015","unstructured":"Takagi S, Suzuki I, Watanabe S (2015) Risk of thromboembolism in patients with immune thrombocytopenia 3(1):9","journal-title":"Risk of thromboembolism in patients with immune thrombocytopenia"},{"issue":"1","key":"4668_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00059-010-3262-1","volume":"35","author":"AN Neskovic","year":"2010","unstructured":"Neskovic AN, Stankovic I, Milicevic P et al (2010) Primary PCI for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. Herz 35(1):43\u201349. https:\/\/doi.org\/10.1007\/s00059-010-3262-1","journal-title":"Herz"},{"issue":"1","key":"4668_CR30","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1182\/asheducation-2017.1.400","volume":"2017","author":"CE Neunert","year":"2017","unstructured":"Neunert CE (2017) Management of newly diagnosed immune thrombocytopenia: can we change outcomes? Hematology 2017(1):400\u2013405. https:\/\/doi.org\/10.1182\/asheducation-2017.1.400","journal-title":"Hematology"},{"key":"4668_CR31","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijcard.2016.05.045","volume":"218","author":"NR Smilowitz","year":"2016","unstructured":"Smilowitz NR, Weiss MC, Mauricio R et al (2016) Provoking conditions, management and outcomes of type 2 myocardial infarction and myocardial necrosis. Int J Cardiol 218:196\u2013201. https:\/\/doi.org\/10.1016\/j.ijcard.2016.05.045","journal-title":"Int J Cardiol"},{"issue":"1","key":"4668_CR32","doi-asserted-by":"publisher","first-page":"e84285","DOI":"10.1371\/journal.pone.0084285","volume":"9","author":"GY Stein","year":"2014","unstructured":"Stein GY, Herscovici G, Korenfeld R et al (2014) Type-II myocardial infarction\u2014patient characteristics, management and outcomes. PLoS One 9(1):e84285. https:\/\/doi.org\/10.1371\/journal.pone.0084285","journal-title":"PLoS One"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04668-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-021-04668-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04668-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T15:08:56Z","timestamp":1641222536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-021-04668-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["4668"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04668-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"assertion":[{"value":"2 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}